Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FAAH | O00519 | 1/20 | 0.34 |
| ▸ | MAPT | P10636 | 1/20 | 0.34 |
| ▸ | CA1 | P00915 | 1/20 | 0.30 |
| ▸ | CA2 | P00918 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1788899 | 0.86 | LMNA (0.35) | — | |
| SCHEMBL7146084 | 0.83 | — | — | |
| SCHEMBL7755301 | 0.81 | DGKA (0.33) | FAAH | |
| SCHEMBL9737113 | 0.79 | FAAH (0.51) | FAAHMAPTCA1 | |
| SCHEMBL1100758 | 0.78 | CA1 (0.41) | CA1CA2 | |
| SCHEMBL1100608 | 0.78 | ALDH1A1 (0.36) | — | |
| SCHEMBL6155074 | 0.77 | TSHR (0.36) | — | |
| SCHEMBL1070843 | 0.77 | HDAC1 (0.34) | — | |
| SCHEMBL7225645 | 0.75 | MAPT (0.36) | MAPT | |
| SCHEMBL5872657 | 0.74 | TSHR (0.34) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1792889-B1 | Process for the preparation of carboxylic acid esters | SUMITOMO CHEMICAL CO (JP) | 2015-03-04 | — | — | EP | disclosed |
| EP-1792889-A2 | Process for the preparation of carboxylic acid esters | Sumitomo Chemical Company, Limited (JP) | 2007-06-06 | — | — | EP | disclosed |
| US-7102019-B2 | Cosmetic and pharmaceutical preparations comprising ascorbic acid derivatives | BASF AKTIENGESELLSCHAFT (DE) | 2006-09-05 | — | — | US | disclosed |
| EP-0917871-B1 | Cosmetic and pharmaceutical compositions comprising ascorbic acid derivatives | BASF AG (DE) | 2006-06-28 | — | — | EP | disclosed |
| US-6407127-B2 | 3-(4-(2-(5H-DIBENZO(A,D)CYCLOHEPTEN-5-YLOXY)-ETHOXYL-PHENYL)-2 -ETHOXY-PROPIONIC ACID ETHYL ESTER AS ANTIDIABETIC AGENTS AND TO TREAT OBESITY | NOVO NORDISK A/S (DK) | 2002-06-18 | — | — | US | disclosed |
| US-20020034527-A1 | Cosmetic and pharmaceutical preparations comprising ascorbic acid derivatives | STREICHER HARALD (DE) | 2002-03-21 | — | — | US | disclosed |
| US-20010031764-A1 | Compounds useful in the treatment of conditions mediated by peroxisome proliferator-activated receptors(PPAR) | JEPPESEN LONE (DK) | 2001-10-18 | — | — | US | disclosed |
| EP-0961774-A1 | PYRAZOL-4-YL-BENZOYL DERIVATIVES AND THEIR USE AS HERBICIDES | BASF AKTIENGESELLSCHAFT (DE) | 1999-12-08 | — | — | EP | disclosed |
| EP-0917871-A2 | Cosmetic and pharmaceutical compositions comprising ascorbic acid derivatives | BASF AKTIENGESELLSCHAFT (DE) | 1999-05-26 | — | — | EP | disclosed |
| WO-1997009327-A1 | PYRAZOL-4-YL-BENZOYL DERIVATIVES AND THEIR USE AS HERBICIDES | BASF AKTIENGESELLSCHAFT (DE) | 1997-03-13 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020034527-A1 | Cosmetic and pharmaceutical preparations comprising ascorbic acid derivatives | PROC, ALDH16A1, RCN1 | FAAH 744/4885MAPT 4493/4885CA1 601/4885 |
| US-20010031764-A1 | Compounds useful in the treatment of conditions mediated by peroxisome proliferator-activated receptors(PPAR) | PPARG, PPARA, PPARD | FAAH 1147/4885MAPT 4634/4885CA1 4709/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.